Article

Bausch & Lomb appoints new CEO

Bausch & Lomb announced it has appointed Gerald M. Ostrov as chairman and chief executive officer to succeed Ronald Zarella.

Rochester, NY

-Bausch & Lomb announced it has appointed Gerald M. Ostrov as chairman and chief executive officer to succeed Ronald Zarella.

Ostrov, 58, most recently was company group chairman, worldwide vision care, for Johnson & Johnson from 1998 to 2006. He first joined Johnson & Johnson in 1976, before leaving for Ciba-Geigy AG in 1982. He returned to Johnson & Johnson in 1991.

Zarella, also 58, took over at Bausch & Lomb in 2001 and will retire in March but will stay on as chairman emeritus. He previously served as chairman and president of General Motors Corp.

"It's an honor to lead Bausch & Lomb into a growth period, one that we believe will be marked by considerable success across the vision care, pharmaceutical and surgical businesses," Ostrov said in a prepared statement.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.